Takeda Pharmaceuticals Advances Digital Transformation with SAP Cloud ERP
Takeda Pharmaceuticals has embarked on a comprehensive digital transformation initiative, transitioning its foundational infrastructure from the legacy SAP ERP Central Component system to modern cloud applications. This migration leverages the RISE with SAP program to modernize enterprise operations, streamline workflows, and prepare the organization for advanced data analytics and artificial intelligence integration.
Modernizing Global Operations
With a history spanning two and a half centuries and a workforce numbering 50,000, Takeda distributes pharmaceutical treatments to patients across more than 80 countries. The organization relies on its enterprise software architecture to manage critical functions globally. Roland Straub, global business transformation lead for Supply Chain at Takeda, noted that enterprise systems underpin nearly every operational workflow, encompassing manufacturing, supply chain management, finance, and quality assurance.
- Upgrading from legacy systems to cloud-based architecture
- Integrating data and digital capabilities into core business strategy
- Streamlining complex global workflows across manufacturing and supply chain
Emphasizing Regulated Automation and AI
The transition forms a key pillar of Takeda strategy to incorporate emerging technological capabilities into daily business operations. By adopting SAP Cloud ERP, the biotech enterprise aims to reduce procedural complexity while establishing a robust foundation for embedded intelligence. This technological shift aligns with industry concepts focusing on autonomous enterprise operations, where automated systems support human decision-makers while maintaining strict compliance within highly regulated environments.
- Co-developing agentic functionalities tailored for regulated life sciences
- Connecting supply chain, production, and quality control processes
- Maintaining strict regulatory compliance while reducing manual workloads
Looking forward, leadership at Takeda views the migration as an ongoing evolution rather than a singular technical milestone. By deepening its collaboration with software providers on industry-specific innovations, the pharmaceutical company seeks to establish scalable methodologies that can benefit the broader life sciences sector while maintaining its core focus on patient outcomes.